THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 110 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2019. The put-call ratio across all filers is 2.28 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $359,000 | +15.1% | 17,592 | 0.0% | 0.08% | +5.6% |
| Q4 2020 | $312,000 | +109.4% | 17,592 | +74.4% | 0.07% | +108.8% |
| Q3 2020 | $149,000 | -30.0% | 10,088 | -0.8% | 0.03% | -46.0% |
| Q2 2020 | $213,000 | -10.1% | 10,166 | -0.9% | 0.06% | -64.6% |
| Q1 2020 | $237,000 | -18.0% | 10,258 | -8.3% | 0.18% | +67.9% |
| Q4 2019 | $289,000 | +33.2% | 11,184 | 0.0% | 0.11% | -16.5% |
| Q3 2019 | $217,000 | +2.8% | 11,184 | -13.6% | 0.13% | +28.3% |
| Q2 2019 | $211,000 | -90.7% | 12,942 | -87.0% | 0.10% | -87.9% |
| Q1 2019 | $2,263,000 | -19.7% | 99,866 | -9.4% | 0.82% | +7.6% |
| Q4 2018 | $2,819,000 | -22.4% | 110,178 | -1.0% | 0.76% | -49.3% |
| Q3 2018 | $3,634,000 | +44.3% | 111,261 | +0.1% | 1.50% | +18.5% |
| Q2 2018 | $2,519,000 | -5.0% | 111,101 | +1.6% | 1.27% | -17.1% |
| Q1 2018 | $2,651,000 | -16.5% | 109,320 | -4.0% | 1.53% | -15.5% |
| Q4 2017 | $3,175,000 | -18.6% | 113,862 | -0.1% | 1.81% | -11.8% |
| Q3 2017 | $3,901,000 | -18.9% | 113,942 | -5.7% | 2.05% | -20.2% |
| Q2 2017 | $4,811,000 | -7.4% | 120,777 | -14.4% | 2.57% | -6.9% |
| Q1 2017 | $5,198,000 | +213.5% | 141,174 | +171.4% | 2.76% | +172.4% |
| Q4 2016 | $1,658,000 | +0.2% | 52,016 | +13.9% | 1.01% | -15.8% |
| Q3 2016 | $1,654,000 | +69.3% | 45,654 | +6.0% | 1.20% | +68.7% |
| Q2 2016 | $977,000 | +33.7% | 43,081 | +10.8% | 0.71% | +16.5% |
| Q1 2016 | $731,000 | +3.0% | 38,888 | -10.3% | 0.61% | -4.5% |
| Q4 2015 | $710,000 | +15.3% | 43,367 | -22.7% | 0.64% | +37.0% |
| Q3 2015 | $616,000 | +31.1% | 56,126 | +55.3% | 0.47% | +43.1% |
| Q2 2015 | $470,000 | +38.2% | 36,129 | +84.2% | 0.33% | +42.8% |
| Q1 2015 | $340,000 | +15.3% | 19,617 | -1.0% | 0.23% | +25.8% |
| Q4 2014 | $295,000 | +17.1% | 19,811 | +80.7% | 0.18% | +14.5% |
| Q3 2014 | $252,000 | – | 10,961 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Link Fund Solutions Ltd | 5,251,349 | $135,459,000 | 69.86% |
| Chescapmanager LLC | 949,006 | $24,570,000 | 3.61% |
| Baupost Group | 9,309,168 | $241,014,000 | 2.66% |
| Rock Springs Capital Management LP | 655,200 | $16,963,000 | 0.54% |
| Rubric Capital Management LP | 173,400 | $4,489,000 | 0.51% |
| Newtyn Management, LLC | 173,300 | $4,487,000 | 0.41% |
| NJ State Employees Deferred Compensation Plan | 38,142 | $988,000 | 0.17% |
| King Wealth Management Group | 22,500 | $583,000 | 0.15% |
| Virtus ETF Advisers LLC | 29,216 | $756,000 | 0.12% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 452,615 | $11,718,000 | 0.12% |